Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
暂无分享,去创建一个
Iver Petersen | Glen Kristiansen | Thomas Knösel | M. Garber | I. Petersen | G. Kristiansen | T. Knösel | Yuan-Hua Chen | Iwata Ozaki | Sachiko Matsuhashi | Yuan Chen | Agnieszka Pietas | Mitchell E Garber | I. Ozaki | S. Matsuhashi | A. Piętas | Agnieszka Piętas
[1] M. Pacyna‐Gengelbach,et al. Gene expression profiles in human non-small and small-cell lung cancers. , 2003, European journal of cancer.
[2] Richard A. Szucs,et al. TNM Classification of Malignant Tumors. 5th ed , 1998 .
[3] H. Kizaki,et al. Cloning of the TIS gene suppressed by topoisomerase inhibitors. , 1998, Gene.
[4] K. Klempnauer,et al. The chicken Pdcd4 gene is regulated by v-Myb , 2001, Oncogene.
[5] G. Strauss. The Mayo Lung Cohort: a regression analysis focusing on lung cancer incidence and mortality. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Honjo,et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. , 1995, Gene.
[7] Ahmedin Jemal,et al. Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.
[8] R H Hruban,et al. Gene expression profiles in normal and cancer cells. , 1997, Science.
[9] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[10] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Petersen,et al. Gene expression profiling of advanced lung cancer , 2000, International journal of cancer.
[12] M. D. David S. Schrump,et al. Targets for Molecular Intervention in Multistep Pulmonary Carcinogenesis , 2001, World Journal of Surgery.
[13] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[14] M. Volm,et al. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival , 2000, British Journal of Cancer.
[15] Spyro Mousses,et al. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. , 2002, Cancer research.
[16] N. Colburn,et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Sasaki,et al. Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer , 2001, International journal of cancer.
[18] O. Kallioniemi,et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. , 2000, Cancer research.
[19] H. Moch,et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.
[20] C. Fujiyama,et al. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti‐H731 antibody , 1999, Pathology international.
[21] N. Brünner,et al. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. , 1994, Cancer research.
[22] N. Colburn,et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation , 2001, Oncogene.
[23] H. Moch,et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer , 2002, Oncogene.
[24] Aaron P. Campbell,et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.